Clinical Trials Directory

Trials / Completed

CompletedNCT04026607

Protein Quality to Support Increased Muscle Protein Synthesis

Efficacy of Higher Versus Lower Quality Protein Supplementation to Support Increased Muscle Protein Synthesis in Older Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
McMaster University · Academic / Other
Sex
Male
Age
65 Years – 80 Years
Healthy volunteers
Accepted

Summary

The age-related decline in muscle mass and strength is collectively referred to as sarcopenia. Canadian recommended daily allowance (RDA) for protein intake (0.8 g/kg/d), however, many expert groups have advocated that older persons should increase their daily intake to \~1.2 g/kg/d to support the preservation of muscle mass. The use of plant-based proteins in food formulation has recently become of interest. This study will examine the impact of consuming higher- versus lower-quality protein supplements on muscle protein synthesis in healthy older men.

Detailed description

This study will examine the impact of consuming higher- versus lower-quality protein supplements on the integrated rates of muscle protein synthesis in healthy older men. Briefly, participants will consume dietary protein at the RDA for the entire duration of the protocol (2 weeks). Participants will be randomized to consuming collagen (control - CON), whey (WHEY), or pea (PEA) protein supplements twice daily for one week. We will examine the ability of different qualities of protein supplements to stimulate integrated rates of muscle protein synthesis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProtein SupplementationParticipants will continue to ingest the standardized diet; however, supplements will be consumed twice daily (25g per serving x 2 servings/day or 50g supplemental protein/day)

Timeline

Start date
2019-12-01
Primary completion
2023-01-31
Completion
2023-01-31
First posted
2019-07-19
Last updated
2023-04-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04026607. Inclusion in this directory is not an endorsement.